Novel Biomarkers for Cardiovascular Risk Assessment: Current Status and Future Directions

James P. MacNamara(Parkland Health & Hospital System), Laurence Sperling(Emory University), Arshed A. Quyyumi(Emory University), Danny J. Eapen(Emory University)
Future Cardiology
September 1, 2015
10.2217/fca.15.39
Cited by 20

Related Papers

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
|Circulation|2019|6.2k
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
|Journal of the American College of Cardiology|2018|2.6k
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary
|Journal of the American College of Cardiology|2018|1.7k
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
|Circulation|2019|903
The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm
|Nature Genetics|2008|727